Armistice Capital’s Medicus Pharma Warrant MDCXW Stock Holding History

Armistice Capital’s Portfolio MDCXW Stock Details MDCXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.4K	Hold	60,600	–	–	﹤0.01%	321
2026 Q1	$57.6K	Hold	60,600	–	–	﹤0.01%	251
2025 Q4	$48.5K	Hold	60,600	–	–	﹤0.01%	354
2025 Q3	$43.6K	Hold	60,600	–	–	﹤0.01%	322
2025 Q2	$53.5K	Hold	60,600	–	–	﹤0.01%	190
2025 Q1	$42.4K	Buy	+60,600	New	+$62.8K	﹤0.01%	213

Other funds holding MDCXW

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Armistice Capital's MDCXW Position: Q2 2026 in Review

Armistice Capital held its Medicus Pharma Warrant (MDCXW) position steady in Q2 2026 at 60,600 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

Armistice Capital first reported a position in MDCXW in Q1 2025 and has held it in 6 quarters since. The position peaked at $57.6K in Q1 2026. 4 funds tracked by Wall St. Rank hold MDCXW as of Q2 2026.

Armistice Capital held 60,600 shares of Medicus Pharma Warrant worth $39.4K as of Q2 2026.
Armistice Capital left its Medicus Pharma Warrant share count unchanged in Q2 2026.
Medicus Pharma Warrant made up ﹤0.01% of Armistice Capital's portfolio in Q2 2026, its #321 holding.
Armistice Capital first reported a position in Medicus Pharma Warrant in Q1 2025 and has held it in 6 quarters since.
Armistice Capital's Medicus Pharma Warrant position peaked at $57.6K in Q1 2026.
4 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.